148 related articles for article (PubMed ID: 31140648)
1. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.
Liu A; Zhang D; Yang X; Song Y
J Cell Biochem; 2019 Oct; 120(10):17593-17601. PubMed ID: 31140648
[TBL] [Abstract][Full Text] [Related]
2. Exploring the association mechanism between metastatic osteosarcoma and non-metastatic osteosarcoma based on dysfunctionality module.
Xiong J; Li T
J BUON; 2020; 25(3):1569-1578. PubMed ID: 32862606
[TBL] [Abstract][Full Text] [Related]
3. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
Ring KL; Yates MS; Schmandt R; Onstad M; Zhang Q; Celestino J; Kwan SY; Lu KH
Int J Gynecol Cancer; 2017 Jun; 27(5):854-862. PubMed ID: 28498246
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive multi-factor analysis and exploration for the pathogenesis of non-ischemic cardiomyopathy and ischemic cardiomyopathy.
Li F; Cheng L; Ma L
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):66-72. PubMed ID: 33040816
[TBL] [Abstract][Full Text] [Related]
8. Time series expression patterns reveal the molecular processes of pancreatic cancer progression.
Zhong Y; Cheng F; Yang M; Song H; Zhao R
J BUON; 2020; 25(4):1960-1968. PubMed ID: 33099939
[TBL] [Abstract][Full Text] [Related]
9. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
10. SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.
Penolazzi L; Bonaccorsi G; Gafà R; Ravaioli N; Gabriele D; Bosi C; Lanza G; Greco P; Piva R
Gene; 2019 Aug; 711():143938. PubMed ID: 31220580
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway.
Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y
Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Liu GM; Ji X; Lu TC; Duan LW; Jia WY; Liu Y; Sun ML; Luo YG
World J Gastroenterol; 2019 Dec; 25(48):6890-6901. PubMed ID: 31908393
[TBL] [Abstract][Full Text] [Related]
13. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of peroxisome proliferator-activated receptor γ inhibits estrogen receptor α transcriptional activity in endometrial carcinoma cells.
Zhang G; Hou X; Gao S
Oncol Rep; 2015 Mar; 33(3):1227-34. PubMed ID: 25592200
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
Chen Z; Yang HJ; Lin Q; Zhu MJ; Yu YY; He XY; Wan XP
Cell Commun Signal; 2020 Jun; 18(1):84. PubMed ID: 32503542
[TBL] [Abstract][Full Text] [Related]
17. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
18. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
19. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
20. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
